Enzymatically active cathepsin D sensitizes breast carcinoma cells to TRAIL

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Tumor Biology

• Publication date

  2016-02-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s13277-016-4958-5PMID 26867770
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sensitivity to anti-Fas is independent of increased cathepsin D activity and adrenodoxin reductase expression occurring in NOS-3 overexpressing HepG2 cells.

  2015cited by this paper
• The endolysosomal system in cell death and survival.

  2013cited by this paper
• Cathepsin D activity and selectivity in the acidic conditions of a tumor microenvironment: Utilization in the development of a novel Cathepsin D substrate for simultaneous cancer diagnosis and therapy.

  2013cited by this paper
• Combating apoptosis and multidrug resistant cancers by targeting lysosomes.

  2013cited by this paper
• Acetate-induced apoptosis in colorectal carcinoma cells involves lysosomal membrane permeabilization and cathepsin D release

  2013cited by this paper
• Inhibition of vacuolar ATPase attenuates the TRAIL‐induced activation of caspase‐8 and modulates the trafficking of TRAIL receptosomes

  2013cited by this paper
• Resistance to TRAIL in non-transformed cells is due to multiple redundant pathways

  2013cited by this paper
• Cathepsin D Primes Caspase-8 Activation by Multiple Intra-chain Proteolysis*

  2012cited by this paper
• c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis

  2012cited by this paper
• Lysosome-mediated apoptosis is associated with cathepsin D-specific processing of bid at Phe24, Trp48, and Phe183.

  2012cited by this paper
• Cysteine cathepsins are not critical for TRAIL- and CD95-induced apoptosis in several human cancer cell lines

  2012cited by this paper
• The Apaf-1-binding protein Aven is cleaved by Cathepsin D to unleash its anti-apoptotic potential

  2012cited by this paper
• Cathepsin D inhibits oxidative stress-induced cell death via activation of autophagy in cancer cells.

  2012cited by this paper
• TRAIL: a sword for killing tumors.

  2010cited by this paper
• New insights into cathepsin D in mammary tissue development and remodeling

  2010cited by this paper
• Lucanthone Is a Novel Inhibitor of Autophagy That Induces Cathepsin D-mediated Apoptosis*

  2010cited by this paper
• Pathophysiological functions of cathepsin D: Targeting its catalytic activity versus its protein binding activity?

  2010cited by this paper
• Leukocyte Elastase Inhibitor, the precursor of L-DNase II, inhibits apoptosis by interfering with caspase-8 activation.

  2008cited by this paper
• The propeptide of cathepsin D increases proliferation, invasion and metastasis of breast cancer cells.

  2008cited by this paper
• Cysteine Cathepsins Trigger Caspase-dependent Cell Death through Cleavage of Bid and Antiapoptotic Bcl-2 Homologues*

  2008cited by this paper
• Cathepsin D--many functions of one aspartic protease.

  2008cited by this paper
• Cathepsin D protects human neuroblastoma cells from doxorubicin-induced cell death.

  2008cited by this paper
• Tumor Necrosis Factor-related Apoptosis-inducing Ligand Activates a Lysosomal Pathway of Apoptosis That Is Regulated by Bcl-2 Proteins*

  2007cited by this paper
• The catalytically inactive precursor of cathepsin D induces apoptosis in human fibroblasts and HeLa cells

  2007cited by this paper
• Pepstatin A, an aspartic proteinase inhibitor, suppresses RANKL-induced osteoclast differentiation.

  2006cited by this paper
• Overexpression of both catalytically active and -inactive cathepsin D by cancer cells enhances apoptosis-dependent chemo-sensitivity

  2006cited by this paper
• Cytosolic acidification and lysosomal alkalinization during TNF-α induced apoptosis in U937 cells

  2006cited by this paper
• Catalytically inactive human cathepsin D triggers fibroblast invasive growth

  2005cited by this paper
• Involvement of cathepsin D in chemotherapy-induced cytochrome c release, caspase activation, and cell death

  2005cited by this paper
• Cooperative Cytotoxicity of Proteasome Inhibitors and Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand in Chemoresistant Bcl-2-Overexpressing Cells

  2005cited by this paper
• Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation

  2004cited by this paper
• Stress-induced apoptosis is impaired in cells with a lysosomal targeting defect but is not affected in cells synthesizing a catalytically inactive cathepsin D

  2003cited by this paper
• Pepstatin A induces extracellular acidification distinct from aspartic protease inhibition in microglial cell lines

  2003cited by this paper
• Cathepsin D Triggers Bax Activation, Resulting in Selective Apoptosis-inducing Factor (AIF) Relocation in T Lymphocytes Entering the Early Commitment Phase to Apoptosis*

  2003cited by this paper
• Cathepsin D mediates cytochrome c release and caspase activation in human fibroblast apoptosis induced by staurosporine

  2003cited by this paper
• Endosomal-Lysosomal Proteolysis Mediates Death Signalling by TNFα, Not by Etoposide, in L929 Fibrosarcoma Cells: Evidence for an Active Role of Cathepsin D

  2002cited by this paper
• Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells

  2002cited by this paper
• Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis

  2002cited by this paper
• Lysosomal proteases as potential targets for the induction of apoptotic cell death in human neuroblastomas

  2002cited by this paper
• Prognostic factors in breast cancer

  2002cited by this paper
• Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

  2000cited by this paper
• Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

  2000cited by this paper
• Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis

  2000cited by this paper
• Safety and antitumor activity of recombinant soluble Apo2 ligand.

  1999cited by this paper
• Cathepsin D expression by cancer and stromal cells in breast cancer: an immunohistochemical study of 1348 cases

  1999cited by this paper
• Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5.

  1999cited by this paper
• Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo

  1999cited by this paper
• Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis.

  1998cited by this paper
• Two CD95 (APO‐1/Fas) signaling pathways

  1998cited by this paper
• Potential role for Cathepsin D in p53-dependent tumor suppression and chemosensitivity

  1998cited by this paper
• BCL‐2, a novel regulator of apoptosis

  1996cited by this paper
• Cathepsin D protease mediates programmed cell death induced by interferon‐gamma, Fas/APO‐1 and TNF‐alpha.

  1996cited by this paper
• Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency.

  1990cited by this paper
• The biogenesis of lysosomes.

  1989cited by this paper
• Estimation of cell survival by flow cytometric quantification of fluorescein diacetate/propidium iodide viable cell number.

  1989cited by this paper
• The aspartic proteinase inhibitor pepstatin, enters mouse peritoneal macrophages by adsorptive pinocytosis.

  1983cited by this paper
• The FASEB Journal express article 10.1096/fj.00-0708fje. Published online May 18, 2001. The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress

  year unknowncited by this paper

• Cathepsin D promotes acute myeloid leukemia progression through stabilization of the anti-apoptotic proteins

  2025cites this paper
• Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value

  2024cites this paper
• Cathepsin D as a potential therapeutic target to enhance anticancer drug-induced apoptosis via RNF183-mediated destabilization of Bcl-xL in cancer cells

  2022cites this paper
• Cathepsin D inhibitors based on tasiamide B derivatives with cell membrane permeability.

  2022cites this paper
• Differentially Expressed Mitochondrial Proteins in Human MCF7 Breast Cancer Cells Resistant to Paclitaxel

  2019cites this paper
• Design, synthesis, and bioactivities of tasiamide B derivatives as cathepsin D inhibitors

  2019cites this paper
• ‘Patchiness’ and basic cancer research: unravelling the proteases

  2019cites this paper
• Vps10-mediated targeting of Pep4 determines the activity of the vacuole in a substrate-dependent manner

  2019cites this paper
• Lysosomal permeabilization and endoplasmic reticulum stress mediate the apoptotic response induced after photoactivation of a lipophilic zinc(II) phthalocyanine.

  2018cites this paper
• Canine respiratory coronavirus employs caveolin-1-mediated pathway for internalization to HRT-18G cells

  2018cites this paper
• Wedelolactone Acts as Proteasome Inhibitor in Breast Cancer Cells

  2017cites this paper